BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38213579)

  • 1. The role of PDIA3 in oral squamous cell carcinoma and its value as A diagnostic and prognostic biomarker.
    Wang L; Wang X; Zhang J; Duan J; Tang C; Zhang L; Zeng H; Li H; Li Y; Zhou Y
    Heliyon; 2023 Dec; 9(12):e22596. PubMed ID: 38213579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
    Guo H; Li C; Su X; Huang X
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
    [No Abstract]   [Full Text] [Related]  

  • 3. Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.
    Tu Z; Ouyang Q; Long X; Wu L; Li J; Zhu X; Huang K
    Front Immunol; 2022; 13():837512. PubMed ID: 35401558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
    Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
    BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA SAMMSON as a novel potential diagnostic and prognostic biomarker for oral squamous cell carcinoma.
    Zheng X; Tian X; Zhang Q; Shi P; Li S
    J Dent Sci; 2020 Sep; 15(3):329-335. PubMed ID: 32952891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLCE1 as a diagnostic and prognostic biomarker by promoting the growth and progression of oral squamous cell carcinoma.
    Abulaiti Z; Chen L; Xiao Q; Aimaier A; Ma Y; He S; Zhang J; Xu J; Cui X
    J Oral Pathol Med; 2022 Oct; 51(9):771-779. PubMed ID: 36065133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma.
    Cao R; Wu Q; Li Q; Yao M; Zhou H
    PeerJ; 2019; 7():e7360. PubMed ID: 31396442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential prognostic value of a eight ferroptosis-related lncRNAs model and the correlative immune activity in oral squamous cell carcinoma.
    Qiu L; Tao A; Liu F; Ge X; Li C
    BMC Genom Data; 2022 Nov; 23(1):80. PubMed ID: 36384476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma.
    Hou C; Cai H; Zhu Y; Huang S; Song F; Hou J
    Front Oncol; 2020; 10():558596. PubMed ID: 33178587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significance, prognostic value and biological role of lncRNA LINC01793 in oral squamous cell carcinoma.
    Yuan SJ; Li SY; Wang YH; Zhang HF; Hua Y; Wang T
    Arch Oral Biol; 2021 May; 125():105105. PubMed ID: 33713982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.
    Yang Z; Liang X; Fu Y; Liu Y; Zheng L; Liu F; Li T; Yin X; Qiao X; Xu X
    EBioMedicine; 2019 Sep; 47():44-57. PubMed ID: 31409573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
    Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
    BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of prognostic signature of patients with oral squamous cell carcinoma based on pyroptosis-related long non-coding RNAs.
    Xin Y; Zhang J; Jiang Q; Qiu J
    Front Surg; 2022; 9():935765. PubMed ID: 36211292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein disulfide isomerase A3 as novel biomarker for endometrial cancer.
    Yu F; Liu X; Li M; Liu X; Wang X; Guo M
    Front Oncol; 2023; 13():1247446. PubMed ID: 37909009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.
    Zhang J; Wang K; Hainisayimu T; Li H
    Oxid Med Cell Longev; 2022; 2022():9614819. PubMed ID: 36046686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MicroRNA model that can predict the prognosis of oral squamous cell carcinoma based on bioinformatics analysis].
    Zhao G; Li CX; Guo C; Zhu H
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Dec; 38(6):622-627. PubMed ID: 33377337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma.
    Xie GF; Zhao LD; Chen Q; Tang DX; Chen QY; Lu HF; Cai JR; Chen Z
    Drug Des Devel Ther; 2020; 14():1717-1727. PubMed ID: 32440097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and Prognostic Significance of PDIA3 in Cervical Cancer.
    Zhang J; Li H; Li H; Lin D; Wang X; Wang K
    Int J Genomics; 2022; 2022():4382645. PubMed ID: 36406049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel and independent survival prognostic model for OSCC: the functions and prognostic values of RNA-binding proteins.
    Wang S; Liu S; Zhu Y; Zhang B; Yang Y; Li L; Sun Y; Zhang L; Fan L; Hu X; Huang C
    Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):397-409. PubMed ID: 37656222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.